Session Information
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer in Singapore
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
All times listed are in Singapore time (GMT+8)
PL - Plenary
PS - Presidential Symposium
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
IS - Industry Symposium
JICC - Joint IASLC-CAALC-CSCO Session
January 28 Thu
Jan 28 Friday
January 29 Fri
Jan 29 Saturday
January 30 Sat
Jan 30 Sunday
January 31 Sun
Jan 31
-
+
ES07 - Pleural Effusion in a Cancer Patient
- 15:30 - 16:30
- 1/29/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Diagnostics and Interventional Pulmonology
-
+
ES07.01 - Radiological Evaluation of Pleural Effusion in a Cancer Patient
15:30 - 15:45 | Presenter: Yeun-Chung Chang
- Abstract
Loading... -
+
ES07.02 - Role of Pleural Fluid Molecular Markers and PD-L1 Testing
15:45 - 16:00 | Presenter: Zoltan Lohinai
- Abstract
Loading... -
+
ES07.03 - Malignant Pleural Effusion: Patient Presentation and Diagnostic Pathway
16:00 - 16:15 | Presenter: Laura McNaughton
- Abstract
No abstract available for this presentation
-
+
ES07.04 - Chemical Pleurodesis, Indwelling Pleural Catheter or Both for Malignant Pleural Effusion
16:15 - 16:30 | Presenter: Pyng Lee
- Abstract
No abstract available for this presentation
-
+
MA03 - New and Revisited Prognostic Factors in Early Stage Lung Cancer
- 15:30 - 16:30
- 1/29/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Early Stage/Localized Disease
-
+
MA03.01 - Chair
15:30 - 15:30 | Presenter: Peter Licht
- Abstract
No abstract available for this presentation
-
+
MA03.02 - Chair
15:30 - 15:30 | Presenter: Eric Lim
- Abstract
No abstract available for this presentation
-
+
MA03.03 - Subsolid Lesions Exceeding 3cm: Do the Ground-Glass Opacity Components Still Matter?
15:30 - 15:35 | Presenter: fan fan Fan
- Abstract
Loading... -
+
MA03.04 - Gender-specific Radiomics Models for Predicting Recurrence in Early Stage (Stage I, II) Non-Small Cell Lung Cancer (ES-NSCLC) Patients
15:35 - 15:40 | Presenter: Pranjal Vaidya
- Abstract
Loading... -
+
MA03.05 - Hierarchy of Adverse-Prognosis Quality Markers after Curative-Intent Resection of Non-Small Cell Lung Cancer (NSCLC)
15:40 - 15:45 | Presenter: Ray Uyiosa Osarogiagbon
- Abstract
Loading... -
+
MA03.06 - Health-Related Quality of Life in Lung Cancer Patients Undergoing Thoracic Surgery
15:45 - 15:50 | Presenter: Eagan Peters
- Abstract
Loading... -
+
MA03.07 - Discussant
15:50 - 15:55 | Presenter: Wentao Fang
- Abstract
No abstract available for this presentation
-
+
MA03.08 - Impact of COVID-19 Pandemic in the Diagnosis and Prognosis of Lung Cancer
15:55 - 16:00 | Presenter: Roxana Reyes
- Abstract
Loading... -
+
MA03.09 - Can Clinical Variables be used to Provide Better Follow up in Stereotactic Ablative Radiotherapy (SABR) Treated Lung Cancers?
16:00 - 16:05 | Presenter: Nathaniel Luke Hatton
- Abstract
Loading... -
+
MA03.10 - Venous Thromboembolism in Lung Cancer Patients: A Population-Based Study
16:05 - 16:10 | Presenter: Gilly Akhtar-Danesh
- Abstract
Loading... -
+
MA03.11 - Cognitive Bias in Lung Cancer Surgery: The Left Digit Effect
16:10 - 16:15 | Presenter: Chi-fu Jeffrey Yang
- Abstract
Loading... -
+
MA03.12 - Discussant
16:15 - 16:20 | Presenter: Jay M. Lee
- Abstract
No abstract available for this presentation
-
+
MA03.13 - Live Q&A
16:20 - 16:30
- Abstract
No abstract available for this presentation
-
+
OA05 - Value and Quality in Lung Cancer
- 15:30 - 16:30
- 1/29/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Health Services Research/Health Economics
-
+
OA05.01 - Chair
15:30 - 15:30 | Presenter: Narjust Duma
- Abstract
No abstract available for this presentation
-
+
OA05.02 - Chair
15:30 - 15:30 | Presenter: CS Pramesh
- Abstract
No abstract available for this presentation
-
+
OA05.03 - Real-World Global Data on Targeting Epidermal Growth Factor Receptor in Stage III Non-Small Cell Lung Cancer: The Results of the KINDLE Study
15:30 - 15:40 | Presenter: Abdul Rahman Jazieh
- Abstract
Loading... -
+
OA05.04 - Clinical and Economic Impact of the Current Testing Scenario for ALK Rearrangements in Spain Compared to a Hypothetical No-Testing Scenario.
15:40 - 15:50 | Presenter: Ana Laura Ortega Granados
- Abstract
Loading... -
+
OA05.05 - Economic Impact of Next-Generation Sequencing (NGS) vs. Single-gene Testing Strategies to Detect Genomic Alterations (GAs) in mNSCLC in Asia
15:50 - 16:00 | Presenter: Herbert H Loong
- Abstract
Loading... -
+
OA05.06 - Lessons Learned from the Victorian Lung Cancer Registry: Opportunities for Quality Improvement in Lung Cancer Management and Outcomes
16:00 - 16:10 | Presenter: Rob G Stirling
- Abstract
Loading... -
+
OA05.07 - Discussant
16:10 - 16:20 | Presenter: Doreen A Ezeife
- Abstract
No abstract available for this presentation
-
+
OA05.08 - Live Q&A
16:20 - 16:30
- Abstract
No abstract available for this presentation
-
+
ES08 - The Solitary Pulmonary Nodule
- 16:45 - 17:45
- 1/29/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Diagnostics and Interventional Pulmonology
-
+
ES08.01 - Chair
16:45 - 16:45 | Presenter: Haja Mohideen Salahudeen Mohamed
- Abstract
No abstract available for this presentation
-
+
ES08.02 - Chair
16:45 - 16:45 | Presenter: Martin Johnston Phillips
- Abstract
No abstract available for this presentation
-
+
ES08.03 - Evidence Based Evaluation of the Indeterminant Pulmonary Nodule
16:45 - 16:57 | Presenter: Annette McWilliams
- Abstract
No abstract available for this presentation
-
+
ES08.04 - Biomarkers in the Evaluation of Pulmonary Nodule
16:57 - 17:09 | Presenter: James R Jett
- Abstract
Loading... -
+
ES08.05 - Targeting the SPN
17:09 - 17:21 | Presenter: Kwun Fong
- Abstract
No abstract available for this presentation
-
+
ES08.06 - Bronchoscopic Treatment of SPN: Opportunities and Challenges
17:21 - 17:33 | Presenter: David Feller-Kopman
- Abstract
No abstract available for this presentation
-
+
ES08.07 - Live Q&A
17:33 - 17:45
- Abstract
No abstract available for this presentation
-
+
MA04 - Health Policy and the Real World
- 16:45 - 17:45
- 1/29/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Health Services Research/Health Economics
-
+
MA04.01 - A Comparative Analysis of Lung Cancer Policies Across the Asia-Pacific Region
16:45 - 16:50 | Presenter: Rohini Omkar Prasad
- Abstract
Loading... -
+
MA04.02 - Lung Cancer Screening Utilization and Its Correlates in Sexual Minorities: An Analysis of the BRFSS 2018
16:50 - 16:55 | Presenter: Hui Xie
- Abstract
Loading... -
+
MA04.03 - Impact of Frailty Screening and Geriatrician-Led Comprehensive Geriatric Assessment in Frail Older Adults With Lung Cancer
16:55 - 17:00 | Presenter: Isabelle Lucy Rosemary Milner
- Abstract
Loading... -
+
MA04.04 - Assessing the Methodological Quality of Quality-of-Life Analyses in First-Line Lung Cancer Trials: A Systematic Review
17:00 - 17:05 | Presenter: Federico Daniel Waisberg
- Abstract
Loading... -
+
MA04.05 - Discussant
17:05 - 17:15 | Presenter: Pamela Samson
- Abstract
No abstract available for this presentation
-
+
MA04.06 - Clinical Characteristics and Outcomes in Advanced KRAS Mutant NSCLC – A Multi-Centre Collaboration in Asia (ATORG-005)
17:15 - 17:20 | Presenter: Jiyun Lee
- Abstract
Loading... -
+
MA04.07 - Comparative Clinical Outcomes for Patients with NSCLC Harboring EGFR Exon 20 Insertion Mutations and Common EGFR Mutations
17:20 - 17:25 | Presenter: Nicolas Girard
- Abstract
Loading... -
+
MA04.08 - The Effect of Packed Red Blood Cell Transfusions on the Clinical Efficacy of Immunotherapy in Non-Small Cell Lung Cancer Patients
17:25 - 17:30 | Presenter: Christopher Andrew D'Avella
- Abstract
Loading... -
+
MA04.09 - Impacts of Multidisciplinary Meeting Presentation: Drivers and Outcomes from a Population Registry Retrospective Cohort Study
17:30 - 17:35 | Presenter: Tiffany Lin
- Abstract
Loading... -
+
MA04.10 - Discussant
17:35 - 17:45 | Presenter: Mark Doherty
- Abstract
No abstract available for this presentation
-
+
OA06 - Updates on EGFR Targeted Perioperative Therapy and Precision Adjuvant Chemotherapy
- 16:45 - 17:45
- 1/29/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Early Stage/Localized Disease
-
+
OA06.01 - Chair
16:45 - 16:45 | Presenter: Sun Min Lim
- Abstract
No abstract available for this presentation
-
+
OA06.02 - Chair
16:45 - 16:45 | Presenter: Boris Sepesi
- Abstract
No abstract available for this presentation
-
+
OA06.03 - Patient-Reported Outcomes from ADAURA: Osimertinib as Adjuvant Therapy in Patients with Resected EGFR Mutated (EGFRm) NSCLC
16:45 - 16:55 | Presenter: Margarita Majem
- Abstract
Loading... -
+
OA06.04 - Postoperative Chemotherapy Use and Outcomes from ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR Mutated NSCLC
16:55 - 17:05 | Presenter: Yi-long Wu
- Abstract
Loading... -
+
OA06.05 - Molecular and Clinical Features Associated with Relapse in Early Stage EGFR-Mutated NSCLC: A Single Institution Knowledge Bank
17:05 - 17:15 | Presenter: Stephanie Pei Li Saw
- Abstract
Loading... -
+
OA06.06 - Clinical/Biomarker Data for Neoadjuvant Atezolizumab in Resectable Stage IB-IIIB NSCLC: Primary Analysis in the LCMC3 Study
17:15 - 17:25 | Presenter: David Paul Carbone
- Abstract
Loading... -
+
OA06.07 - Discussant
17:25 - 17:35 | Presenter: Haiquan Chen
- Abstract
No abstract available for this presentation
-
+
OA06.08 - Live Q&A
17:35 - 17:45
- Abstract
No abstract available for this presentation
-
+
PL03 - Bench to Bedside (Immunology) (Japanese, Mandarin, Spanish Translation Available)
- 18:00 - 20:00
- 1/29/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Plenary
- Track: N.A.
-
+
PL03.01 - Chair
18:00 - 18:00 | Presenter: Silvia Novello
- Abstract
No abstract available for this presentation
-
+
PL03.02 - Chair
18:00 - 18:00 | Presenter: Benjamin Besse
- Abstract
No abstract available for this presentation
-
+
PL03.03 - NSCLC and Immune Evasion: Insights from TRACERx
18:00 - 18:20 | Presenter: Charles Swanton
- Abstract
No abstract available for this presentation
-
+
PL03.04 - Considering Biology of "Nodes" in Response to PD-1 Blockade in NSCLC
18:20 - 18:40 | Presenter: Matthew D Hellmann
- Abstract
No abstract available for this presentation
-
+
PL03.05 - Cell Therapy for Solid Tumors
18:40 - 19:00 | Presenter: Prasad S Adusumilli
- Abstract
Loading... -
+
PL03.06 - Improving Outcomes with Immunotherapy: Lessons from Other Diseases
19:00 - 19:20 | Presenter: Carolyn Roberts
- Abstract
Loading... -
+
PL03.07 - Monitoring Disease Through Genomic/Immune Markers
19:20 - 19:40 | Presenter: Qing Zhou
- Abstract
No abstract available for this presentation
-
+
PL03.08 - Live Q&A
19:40 - 20:00
- Abstract
No abstract available for this presentation
-
+
PS01 - Presidential Symposium (Japanese, Mandarin, Spanish Translation Available)
- 07:00 - 09:00
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Plenary
- Track: N.A.
-
+
PS01.01 - Welcome Video
07:00 - 07:02
- Abstract
No abstract available for this presentation
-
+
PS01.02 - National Lung Cancer Screening Program in Taiwan: The TALENT Study
07:02 - 07:12 | Presenter: Pan-Chyr Yang
- Abstract
Loading... -
+
PS01.03 - Discussant
07:12 - 07:20 | Presenter: Ugo Pastorino
- Abstract
No abstract available for this presentation
-
+
PS01.04 - International Tailored Chemotherapy Adjuvant Trial : ITACA Trial. Final Results
07:20 - 07:30 | Presenter: Silvia Novello
- Abstract
Loading... -
+
PS01.05 - Surgical and Clinical Outcomes With Neoadjuvant Atezolizumab in Resectable Stage IB–IIIB NSCLC: LCMC3 Trial Primary Analysis
07:30 - 07:40 | Presenter: Jay M. Lee
- Abstract
Loading... -
+
PS01.06 - Discussant
07:40 - 07:50 | Presenter: Shinichi Toyooka
- Abstract
No abstract available for this presentation
-
+
PS01.07 - CodeBreaK 100: Registrational Phase 2 Trial of Sotorasib in KRAS p.G12C Mutated Non-small Cell Lung Cancer
07:50 - 08:00 | Presenter: Bob T. Li
- Abstract
Loading... -
+
PS01.08 - Discussant
08:00 - 08:08 | Presenter: Pasi Antero Jänne
- Abstract
No abstract available for this presentation
-
+
PS01.09 - Pembrolizumab Plus Ipilimumab vs Pembrolizumab Plus Placebo as 1L Therapy for Metastatic NSCLC of PD-L1 TPS ≥50%: KEYNOTE-598
08:08 - 08:18 | Presenter: Michael Boyer
- Abstract
Loading... -
+
PS01.10 - Discussant
08:18 - 08:26 | Presenter: Yun Fan
- Abstract
No abstract available for this presentation
-
+
PS01.11 - Nivolumab Versus Placebo in Relapsed Malignant Mesothelioma: The CONFIRM Phase 3 Trial
08:26 - 08:36 | Presenter: Dean Fennell
- Abstract
Loading... -
+
PS01.12 - Discussant
08:36 - 08:44 | Presenter: Rina Hui
- Abstract
No abstract available for this presentation
-
+
PS01.13 - Live Q&A
08:44 - 09:00
- Abstract
No abstract available for this presentation
-
+
PS01.14 - Chair
07:00 - 07:00 | Presenter: Tetsuya Mitsudomi
- Abstract
No abstract available for this presentation
-
+
ES09 - Biomarkers in Immunotherapy
- 09:15 - 10:15
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
-
+
ES09.01 - Chair
09:15 - 09:15 | Presenter: Katerina Politi
- Abstract
No abstract available for this presentation
-
+
ES09.02 - Chair
09:15 - 09:15 | Presenter: Melina Elpi Marmarelis
- Abstract
No abstract available for this presentation
-
+
ES09.03 - Role of PD-L1 and Tumor Mutational Burden in NSCLC Immunotherapy
09:15 - 09:25 | Presenter: Solange Peters
- Abstract
Loading... -
+
ES09.04 - Individual Genomic Alterations as Predictive Factors for NSCLC Immunotherapy
09:25 - 09:35 | Presenter: Ferdinandos Skoulidis
- Abstract
No abstract available for this presentation
-
+
ES09.05 - Blood-based Biomarkers for Immunotherapy: Applications and Limitations
09:35 - 09:45 | Presenter: Lizza Hendriks
- Abstract
Loading... -
+
ES09.06 - Immune Contexture and Immunotherapy Response in NSCLC
09:45 - 09:55 | Presenter: Kurt Alex Schalper
- Abstract
No abstract available for this presentation
-
+
ES09.07 - Immunotherapy Biomarkers in NSCLC: Looking into the Future
09:55 - 10:05 | Presenter: Vamsidhar Velcheti
- Abstract
No abstract available for this presentation
-
+
ES09.08 - Live Q&A
10:05 - 10:15
- Abstract
No abstract available for this presentation
-
+
ES10 - Advances in Lung Cancer Screening Through Imaging and Data Analytics
- 09:15 - 10:15
- 1/30/2021
- Location: Scientific Program Auditorium
- IASLC CME Accredited
- Type: Educational Session
- Track: Screening and Early Detection
-
+
ES10.01 - Chair
09:15 - 09:15 | Presenter: Charlene J Liew
- Abstract
No abstract available for this presentation
-
+
ES10.02 - Chair
09:15 - 09:15 | Presenter: Yeol Kim
- Abstract
No abstract available for this presentation
-
+
ES10.03 - AI-Enabled Lung Cancer Predictive Analytics - The Future of Lung Cancer Screening?
09:15 - 09:27 | Presenter: Zaiyi Liu
- Abstract
No abstract available for this presentation
-
+
ES10.05 - Size Isn't Everything - Other High-Risk CT Imaging Features
09:27 - 09:39 | Presenter: Heber MacMahon
- Abstract
No abstract available for this presentation
-
+
ES10.06 - Putting It Together: Current Best Practices in the Evaluation and Follow-Up of the Indeterminate Pulmonary Nodule
09:39 - 09:51 | Presenter: David Raymond Baldwin
- Abstract
Loading... -
+
ES10.07 - Live Q&A
09:51 - 10:15
- Abstract
No abstract available for this presentation
first
prev
